88 related articles for article (PubMed ID: 18430402)
1. Trace determination of ethyl methanesulfonate in Viracept 250 mg tablets by gas chromatography-mass spectrometry.
Rebiere H; Maggio AF; Gimeno P; Levaillant D; Civade C; Bonnet PA; Tissier MH
Pharmeur Sci Notes; 2008 Feb; 2008(1):17-20. PubMed ID: 18430402
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate.
Ramakrishna K; Raman NV; Rao KM; Prasad AV; Reddy KS
J Pharm Biomed Anal; 2008 Mar; 46(4):780-3. PubMed ID: 18178357
[TBL] [Abstract][Full Text] [Related]
3. What happened: the chemistry side of the incident with EMS contamination in Viracept tablets.
Gerber C; Toelle HG
Toxicol Lett; 2009 Nov; 190(3):248-53. PubMed ID: 19857795
[TBL] [Abstract][Full Text] [Related]
4. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
5. Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization.
Kakadiya PR; Reddy BP; Singh V; Ganguly S; Chandrashekhar TG; Singh DK
J Pharm Biomed Anal; 2011 May; 55(2):379-84. PubMed ID: 21353429
[TBL] [Abstract][Full Text] [Related]
6. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
Lutz WK
Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a sensitive GC-MS method for the determination of trace levels of an alkylating reagent in a beta-lactam active pharmaceutical ingredient.
Li H; Sluggett GW
J Pharm Biomed Anal; 2005 Sep; 39(3-4):486-94. PubMed ID: 15951149
[TBL] [Abstract][Full Text] [Related]
8. Determination of sulfonate ester genotoxic impurities in imatinib mesylate by gas chromatography with mass spectrometry.
Zhang C; Huang L; Wu Z; Chang C; Yang Z
J Sep Sci; 2016 Sep; 39(18):3558-63. PubMed ID: 27461842
[TBL] [Abstract][Full Text] [Related]
9. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
Müller L; Singer T
Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794
[TBL] [Abstract][Full Text] [Related]
10. Trace analysis of residual methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in pharmaceuticals by capillary gas chromatography with flame ionization detection.
Li W
J Chromatogr A; 2004 Aug; 1046(1-2):297-301. PubMed ID: 15387202
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an automated static headspace gas chromatography-mass spectrometry (SHS-GC-MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid.
Jacq K; Delaney E; Teasdale A; Eyley S; Taylor-Worth K; Lipczynski A; Reif VD; Elder DP; Facchine KL; Golec S; Oestrich RS; Sandra P; David F
J Pharm Biomed Anal; 2008 Dec; 48(5):1339-44. PubMed ID: 18996665
[TBL] [Abstract][Full Text] [Related]
12. Semiautomated determination of pesticides in water using solid phase extraction disks and gas chromatography-mass spectrometry.
Leandro CC; Bishop DA; Fussell RJ; Smith FD; Keely BJ
J Agric Food Chem; 2006 Feb; 54(3):645-9. PubMed ID: 16448162
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A
Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315
[TBL] [Abstract][Full Text] [Related]
14. Determination of melatonin in pharmaceutical formulations and human plasma by gas chromatography-electron impact mass spectrometry.
Covaci A; Doneanu C; Aboul-Enein HY; Schepens P
Biomed Chromatogr; 1999 Oct; 13(6):431-6. PubMed ID: 10477902
[TBL] [Abstract][Full Text] [Related]
15. Validation of a sensitive gas chromatographic-mass spectrometric method for the simultaneous determination of beta-elemene and beta-elemenal in human plasma.
Chen Z; Song Y; Che J; Liu X; Ning Y; Shan C; Hou Y; Liu Y; Miao X; Cheng Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):408-14. PubMed ID: 19124285
[TBL] [Abstract][Full Text] [Related]
16. Capillary GC-MS determination of melatonin in several pharmaceutical tablet formulations.
Aboul-Enein HY; Doneanu C; Covaci A
Biomed Chromatogr; 1999 Feb; 13(1):24-6. PubMed ID: 10191939
[TBL] [Abstract][Full Text] [Related]
17. A rapid and simple procedure for the determination of synephrine in dietary supplements by gas chromatography-mass spectrometry.
Marchei E; Pichini S; Pacifici R; Pellegrini M; Zuccaro P
J Pharm Biomed Anal; 2006 Jun; 41(4):1468-72. PubMed ID: 16698212
[TBL] [Abstract][Full Text] [Related]
18. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
Strano-Rossi S; Molaioni F; Rossi F; Botrè F
Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
[TBL] [Abstract][Full Text] [Related]
19. Analysis of flavonoids in tablets and urine by gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry.
Watson DG; Pitt AR
Rapid Commun Mass Spectrom; 1998; 12(4):153-6. PubMed ID: 9493410
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]